Analysts: Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

12.41USD
24 May 2013
Price Change (% chg)

$0.11 (+0.89%)
Prev Close
$12.30
Open
$12.28
Day's High
$12.41
Day's Low
$11.91
Volume
130,279
Avg. Vol
507,896
52-wk High
$14.09
52-wk Low
$3.92

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month		 Last Updated
Buy -0.22 December 25 May 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago		 2 Month
Ago		 3 Month
Ago
(1) BUY 7 7 7 6
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.12 1.12 1.12 1.14

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-13 5 1.92 3.50 0.10 2.04
Quarter Ending Sep-13 5 1.70 3.50 0.04 2.04
Year Ending Dec-13 5 7.76 12.91 2.70 7.85
Year Ending Dec-14 6 3.73 14.00 0.05 6.93
Earnings (per share)
Quarter Ending Jun-13 5 -0.22 -0.21 -0.23 -0.25
Quarter Ending Sep-13 5 -0.25 -0.23 -0.28 -0.24
Year Ending Dec-13 5 -0.97 -0.92 -1.04 -0.96
Year Ending Dec-14 6 -1.00 -0.81 -1.19 -0.92

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 2.42 2.41 0.00 0.11
Quarter Ending Dec-12 2.44 3.65 1.20 49.19
Quarter Ending Sep-12 2.07 3.11 1.04 50.35
Quarter Ending Jun-12 2.17 2.01 0.16 7.27
Quarter Ending Mar-12 2.25 2.43 0.19 8.30
Earnings (per share)
Quarter Ending Mar-13 -0.22 -0.23 0.01 -4.55
Quarter Ending Dec-12 -0.25 -0.27 0.02 -8.74
Quarter Ending Sep-12 -0.24 -0.25 0.01 -3.43
Quarter Ending Jun-12 -0.25 -0.23 0.02 -9.05
Quarter Ending Mar-12 -0.24 -0.27 0.03 -13.30

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago		 1 Month
Ago		 2 Month
Ago		 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-13 1.92 1.67 1.34 1.34 2.04
Quarter Ending Sep-13 1.70 1.52 1.19 1.19 2.04
Year Ending Dec-13 7.76 7.24 6.13 6.13 7.85
Year Ending Dec-14 3.73 3.73 3.68 3.68 6.93
Earnings (per share)
Quarter Ending Jun-13 -0.22 -0.22 -0.22 -0.22 -0.25
Quarter Ending Sep-13 -0.25 -0.24 -0.24 -0.24 -0.24
Quarter Ending Dec-13 -0.97 -0.95 -0.92 -0.92 -0.96
Quarter Ending Dec-14 -1.00 -1.00 -0.99 -0.99 -0.92

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-13 0 0 2 0
Quarter Ending Sep-13 0 0 2 1
Year Ending Dec-13 0 0 2 3
Year Ending Dec-14 0 0 1 0
Earnings
Quarter Ending Jun-13 0 0 3 2
Quarter Ending Sep-13 0 0 3 1
Year Ending Dec-13 0 0 3 2
Year Ending Dec-14 0 0 2 1

Earnings vs. Estimates

» More Financials

Celldex Therapeutics Inc News

Analyst Research Reports

Report Title Price
CELLDEX THERAPEUTICS INC (CLDX) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Celldex Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Celldex Therapeutics
Provider: S&P Capital IQ Quantitative Report
$69.00
Buy
Thomson Reuters Stock Report - CELLDEX THERAPEUTICS INC. (CLDX-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CELLDEX THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider: Jefferson Research
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks